Vireo Growth (VREOF) Net Margin (2020 - 2026)
Vireo Growth's (VREOF) quarterly Net Margin came in at 21.19% in Q1 2026, up 534.0% year-on-year from 3.34% in Q1 2025, and up 34.45% quarter-over-quarter from 32.32% in Q4 2025.
Vireo Growth (VREOF) Net Margin (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Net Margin across 7 years of filings, most recently posting 21.19% for Q1 2026.
- Net Margin for Q1 2026 came in at 21.19%, up 534.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 27.83% (up 3.0% YoY), and the FY2025 annual result was 30.33%, down 215.0% from the prior year.
- Net Margin came in at 21.19% for Q1 2026 at Vireo Growth, up from 32.32% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 15.88% in Q4 2023 to a low of 113.07% in Q1 2022.
- The 5-year median for Net Margin is 28.69% (2025), against an average of 32.43%.
- Across the five-year window, Net Margin surged 8563 bps in 2022 and sank 7862 bps in 2024, its largest moves.
- Vireo Growth's Net Margin stood at 17.54% in 2022, then soared by 191 bps to 15.88% in 2023, then slumped by 495 bps to 62.75% in 2024, then soared by 48 bps to 32.32% in 2025, then surged by 34 bps to 21.19% in 2026.
- The last three Net Margin figures came in at 21.19% (Q1 2026), 32.32% (Q4 2025), and 28.69% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Vireo Growth | - | - | 59.30 Mn | -21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.19% |
| Dec 31, 2025 | -32.32% |
| Sep 30, 2025 | -28.69% |
| Jun 30, 2025 | -31.07% |
| Mar 31, 2025 | -26.53% |
| Dec 31, 2024 | -62.75% |
| Sep 30, 2024 | -19.58% |
| Jun 30, 2024 | -2.66% |
| Mar 31, 2024 | -27.86% |
| Dec 31, 2023 | 15.88% |
| Sep 30, 2023 | -23.22% |
| Jun 30, 2023 | -36.59% |
| Mar 31, 2023 | -44.37% |
| Dec 31, 2022 | -17.54% |
| Sep 30, 2022 | -50.78% |
| Jun 30, 2022 | -28.94% |
| Mar 31, 2022 | -113.07% |
| Dec 31, 2021 | -103.17% |
| Sep 30, 2021 | -51.16% |
| Jun 30, 2021 | -49.10% |